Teri Oldaker

Flow cytometric method transfer: Recommendations for best practice

Virginia Litwin, Cherie Green, Alessandra Vitaliti, 2020, Cytometry. Part B, Clinical cytometry.

Flow Cytometry Method Validation Protocols

Virginia Litwin, Cherie Green, Alessandra Vitaliti, 2018, Current protocols in cytometry.

High‐sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events

Virginia Litwin, Cherie Green, Alessandra Vitaliti, 2020, Cytometry. Part B, Clinical cytometry.

Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part I – rationale and aims

Teri Oldaker, B. Wood, B. Davis, 2013, Cytometry. Part B, Clinical cytometry.

2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia

Bruce Greig, Brent L Wood, Teri Oldaker, 2007, Cytometry. Part B, Clinical cytometry.

Making the most of your prognostic factors: Presenting a more accurate survival model for breast cancer patients

Teri Oldaker, M. Pandian, G. Clark, 2005, Breast Cancer Research and Treatment.

DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients

Teri Oldaker, W. McGuire, M. Pandian, 1993, Breast Cancer Research and Treatment.